Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JEFFREY J TARRAND and DIMITRIOS P KONTOYIANNIS.
JEFFREY J TARRAND
Connection Strength
5.974
DIMITRIOS P KONTOYIANNIS
  1. Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre. Mycoses. 2018 Nov; 61(11):861-867.
    View in: PubMed
    Score: 0.673
  2. Dimethyl sulfoxide enhances effectiveness of skin antiseptics and reduces contamination rates of blood cultures. J Clin Microbiol. 2012 May; 50(5):1552-7.
    View in: PubMed
    Score: 0.431
  3. Increased culture recovery of Zygomycetes under physiologic temperature conditions. Am J Clin Pathol. 2007 Feb; 127(2):208-12.
    View in: PubMed
    Score: 0.303
  4. Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordance Between Responses of Skin Lesions and Systemic Outcomes. Open Forum Infect Dis. 2024 Feb; 11(2):ofae068.
    View in: PubMed
    Score: 0.247
  5. Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. J Antimicrob Chemother. 2024 Feb 01; 79(2):297-306.
    View in: PubMed
    Score: 0.246
  6. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol. 2003 Jun; 119(6):854-8.
    View in: PubMed
    Score: 0.235
  7. Invasive mould infections in patients from floodwater-damaged areas after hurricane Harvey - a closer look at an immunocompromised cancer patient population. J Infect. 2022 05; 84(5):701-709.
    View in: PubMed
    Score: 0.216
  8. Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis. Front Immunol. 2022; 13:838344.
    View in: PubMed
    Score: 0.215
  9. Cat Scratch Disease as a Mimicker of Malignancy. Open Forum Infect Dis. 2021 Nov; 8(11):ofab500.
    View in: PubMed
    Score: 0.210
  10. Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer. J Fungi (Basel). 2021 Mar 17; 7(3).
    View in: PubMed
    Score: 0.202
  11. Protective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model. J Infect Dis. 2020 08 17; 222(6):989-994.
    View in: PubMed
    Score: 0.194
  12. Corrigendum: Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study. Open Forum Infect Dis. 2019 Nov; 6(11):ofz458.
    View in: PubMed
    Score: 0.184
  13. Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study. Open Forum Infect Dis. 2019 Jul; 6(7):ofz247.
    View in: PubMed
    Score: 0.180
  14. Fulminant Cryptococcus neoformans infection with fatal pericardial tamponade in a patient with chronic myelomonocytic leukaemia who was treated with ruxolitinib: Case report and review of fungal pericarditis. Mycoses. 2018 Apr; 61(4):245-255.
    View in: PubMed
    Score: 0.162
  15. Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often. J Infect. 2017 12; 75(6):572-580.
    View in: PubMed
    Score: 0.158
  16. Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole? Antimicrob Agents Chemother. 2017 08; 61(8).
    View in: PubMed
    Score: 0.157
  17. Time-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients. Diagn Microbiol Infect Dis. 2016 Jul; 85(3):391-393.
    View in: PubMed
    Score: 0.143
  18. Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA. Emerg Infect Dis. 2015 Nov; 21(11):1942-50.
    View in: PubMed
    Score: 0.139
  19. Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis. 2014 Nov; 20(11):1833-40.
    View in: PubMed
    Score: 0.130
  20. Efficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancer. Antimicrob Agents Chemother. 2014 Jun; 58(6):3526-9.
    View in: PubMed
    Score: 0.124
  21. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013 Nov; 56(6):638-45.
    View in: PubMed
    Score: 0.116
  22. Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker? Mycoses. 2013 May; 56(3):311-4.
    View in: PubMed
    Score: 0.113
  23. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect. 2012 Jan; 64(1):68-75.
    View in: PubMed
    Score: 0.106
  24. Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection. Antimicrob Agents Chemother. 2010 Jan; 54(1):484-90.
    View in: PubMed
    Score: 0.092
  25. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer. 2009 Oct 15; 115(20):4745-52.
    View in: PubMed
    Score: 0.091
  26. Legionella pneumonia in cancer patients. Medicine (Baltimore). 2008 May; 87(3):152-159.
    View in: PubMed
    Score: 0.083
  27. Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR. J Med Microbiol. 2007 Jun; 56(Pt 6):778-787.
    View in: PubMed
    Score: 0.078
  28. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006 Jul; 91(7):986-9.
    View in: PubMed
    Score: 0.072
  29. Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery. J Clin Microbiol. 2005 Jan; 43(1):382-6.
    View in: PubMed
    Score: 0.066
  30. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004; 36(8):564-9.
    View in: PubMed
    Score: 0.061
  31. Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. J Neurosurg. 2003 Oct; 99(4):693-700.
    View in: PubMed
    Score: 0.060
  32. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore). 2003 Sep; 82(5):309-21.
    View in: PubMed
    Score: 0.060
  33. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis. 2002 Feb 01; 34(3):400-3.
    View in: PubMed
    Score: 0.053
  34. Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2020 Oct; 22(5):e13395.
    View in: PubMed
    Score: 0.048
  35. Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes. J Clin Microbiol. 2018 10; 56(10).
    View in: PubMed
    Score: 0.042
  36. Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015. Clin Infect Dis. 2017 Jul 15; 65(2):216-225.
    View in: PubMed
    Score: 0.039
  37. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2017 Feb; 19(1).
    View in: PubMed
    Score: 0.038
  38. Fungal empyema thoracis in cancer patients. J Infect. 2016 May; 72(5):615-21.
    View in: PubMed
    Score: 0.036
  39. Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One. 2015; 10(11):e0139851.
    View in: PubMed
    Score: 0.035
  40. Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A. 2013 Feb 26; 110(9):3477-82.
    View in: PubMed
    Score: 0.029
  41. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis. 2011 Sep; 17(9):1651-8.
    View in: PubMed
    Score: 0.026
  42. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine (Baltimore). 2006 Mar; 85(2):86-94.
    View in: PubMed
    Score: 0.018
  43. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar; 6(5):393-8.
    View in: PubMed
    Score: 0.018
  44. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79.
    View in: PubMed
    Score: 0.017
  45. Diagnosis of invasive mold infection by real-time quantitative PCR. Am J Clin Pathol. 2003 Jan; 119(1):38-44.
    View in: PubMed
    Score: 0.014
  46. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol. 2002 Sep; 23(9):532-7.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.